Circulating Tumor Material in Colorectal Cancer and Melanoma

Protocol to Permit the Acquisition of Circulating Tumor Material in Colorectal Cancer and Melanoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02907086

Enrollment

Registered

2016-09-20

Start date

2017-07-07

Completion date

2020-07-01

Last updated

2022-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer and Melanoma

Brief summary

Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma

Interventions

OTHERblood collection

Patients will receive a research draw for circulating tumor material analysis with standard clinical labs

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* The subject must be a patient at the Hospital of the University of Pennsylvania 1. Patients with presumed stage II, III, or IV colorectal cancer with planned surgical resection of either the primary tumor or metastatic lesion(s) being evaluated at the Hospital of the University of Pennsylvania 2. Patients with histologically confirmed melanoma stage IIb, IIc, IIIa, IIIb, or IIIc/IV scheduled for surgical resection being evaluated at the Hospital of the University of Pennsylvania. * The subject must be able to provide informed consent or have an acceptable surrogate capable of giving consent on the subject's behalf. * The subject must be 18 years of age or older.

Exclusion criteria

* The subject is not able to provide informed consent.

Design outcomes

Primary

Measure	Time frame
Number of blood samples collected	24 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026